エクソソーム研究の世界市場予測(~2028):製品・サービス別、疾患別、用途別、製造サービス別

◆英語タイトル:Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028

MarketsandMarketsが発行した調査報告書(BT6939-24)◆商品コード:BT6939-24
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2024年1月20日
◆ページ数:229
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥742,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧)USD6,650 ⇒換算¥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,222,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

"エクソソーム研究市場は、2023年の推定1億6900万米ドルから2028年には3億5600万米ドルに達すると予測され、予測期間中のCAGRは16.0%" この市場の成長は、癌、神経変性疾患、心血管疾患などの慢性疾患の発生率が増加し、高度な診断および治療ソリューションの需要が高まっていることに起因しています。エクソソームは、バイオマーカーや治療デリバリー・ビークルとしての可能性を秘めており、この需要に対応することができます。

"2022年の製品・サービス別シェアは、キット・試薬セグメントが最大"
2022年、世界のエクソソーム研究市場において、製品&サービス別で最大のシェアを占めるのはプラットフォームセグメントです。キットや試薬のような要因は、研究者にすぐに使えるソリューションを提供し、エクソソーム研究に関わる複雑なプロセスを簡素化することで、このセグメントの成長を促しています。これらのキットの利便性とユーザーフレンドリーな性質は、特にエクソソームの単離と分析に関する広範な専門知識を持たない研究者の間で、その普及に貢献しています。

"2023-2028年の予測期間中、北米地域がエクソソーム研究市場を引き続き支配"
北米は2022年に世界のエクソソーム研究市場を支配しました。米国の国立衛生研究所(NIH)などの北米の政府機関は、生物医学研究に多額の資金を割り当てています。この資金は、エクソソーム研究に関連するものを含む幅広いプロジェクトを支援しています。政府の支援は研究者や研究機関に重要な財政的後押しをし、この分野の革新と進歩を促進します。これらの要因が北米のエクソソーム研究市場の成長に寄与しています。

本レポートのために実施した一次インタビューは以下のように分類されます。
- 回答者別:供給側70%、需要側30%
- 役職別:管理職:45%、CXOおよび取締役:30%、経営幹部:25%
- 地域別:北米40%、欧州25%、アジア太平洋地域20%、中南米10%、中東・アフリカ5%

レポート掲載企業一覧
• Thermo Fisher Scientific, Inc. (US)
• Bio-Techne (US)
• System Biosciences, LLC (US)
• QIAGEN (Germany)
• Lonza (Switzerland)
• NX Pharmagen (US)
• NanoSomiX (US)
• Miltenyi Biotech (Germany)
• Norgen Biotek Corp. (Canada)
• AMSBio (UK)
• Aethlon Medical, Inc. (US)
• Anjarium Biosciences AG (UK)
• Ciloa (France)
• InnovaPrep LLC (US)
• Creative Medical Technologies Holdings, Inc. (US)
• ILIAS Biologics, Inc. (South Korea)
• Unchained Labs (US)
• Rion, Inc. (US)
• Cell Guidance System, LLC (UK)
• INOVIQ (Australia)
• Danaher Corporation (US)
• Exopharm (Australia)
• Everzom (France)
• RoosterBio, Inc. (US)
• Creative Biolabs (US)

調査範囲
この調査レポートは、エクソソーム研究市場を、製品・サービス別(試薬・キット(抗体、分離精製、定量キット・試薬、その他キット・試薬)機器、サービス)、適応症別(がん適応症(肺がん、乳がん、前立腺がん、大腸がん、その他がん)、神経変性疾患、心血管疾患、感染症、 その他適応症)、用途別(バイオマーカー、ワクチン開発、組織再生、その他用途)、製造サービス別(幹細胞由来エクソソーム製造サービス、樹状細胞由来エクソソーム製造サービス、その他製造サービス)、エンドユーザー別(学術・研究機関、製薬・バイオテクノロジー企業、病院・臨床研究所)で分析しています。本レポートは、エクソソーム研究市場の成長を形成する促進要因、動向、課題、機会などの主要な影響要因に関する詳細情報を網羅しています。主要な業界プレイヤーを包括的に分析し、事業概要、製品、主要戦略、提携、パートナーシップ、契約に関する洞察を提供しています。また、エクソソーム研究市場における新製品の発売、合併、買収などの最近の動向についても取り上げています。

レポート購入の主な利点
本レポートは、エクソソーム研究市場全体とそのサブセグメントの収益数の最も近い概算値を提供することで、市場リーダー/新規参入者を支援します。また、利害関係者が競争状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置付け、適切な市場参入戦略を立てるのに役立ちます。本レポートは、関係者が市場の鼓動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します。
-主な促進要因(製薬およびライフサイエンス研究への投資の増加、がん罹患率の上昇、エクソソームベースの治療法に対する関心の高まり)、阻害要因(エクソソーム分離の技術的複雑性と技術的限界、エクソソーム研究における規制の不確実性)、機会(エクソソーム研究のための新興国での投資の増加、エクソソームベースの治療法に対する関心の高まり、個別化医療に対する需要の高まり)、および市場の成長に影響を与える課題(エクソソームの開発および製造のためのゴールドスタンダードプロトコルの欠如、カーゴローディングに対する理解の制限)に関する分析を行っています。
-製品開発/イノベーション:エクソソーム研究市場で新たに発売された製品に関する詳細な洞察を提供します。
-市場開発:有利な市場に関する包括的な情報 - 当レポートは様々な地域の市場を分析しています。
-市場の多様化:エクソソーム研究市場における新製品、未開拓地域、最近の開発、投資に関する詳細な情報を提供します。
-競合評価:Thermo Fisher Scientific, Inc. (US), Bio-Techne (US), System Biosciences, LLC (US), QIAGEN (Germany), Lonza (Switzerland), NX Pharmagen (US), NanoSomiX (US), Miltenyi Biotech (Germany), Norgen Biotek Corp. (Canada), AMSBio (UK), Aethlon Medical, Inc. (US), Anjarium Biosciences AG (UK), Ciloa (France), InnovaPrep LLC (US), Creative Medical Technologies Holdings, Inc. (US), ILIAS Biologics, Inc. (South Korea), Unchained Labs (US), Rion, Inc. (US), Cell Guidance System, LLC (UK), INOVIQ (Australia), Danaher Corporation (US), Exopharm (Australia), Everzom (France), RoosterBio, Inc. (US), and Creative Biolabs (US)などの企業情報が含まれています。
❖ レポートの概要 ❖

1 イントロダクション
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 世界のエクソソーム研究市場規模:製品・サービス別
7 世界のエキソソーム研究市場規模:適応症別
8 世界のエクソソーム研究市場規模:用途別
9 世界のエキソソーム研究市場規模:エンドユーザー別
10 世界のエクソソーム研究市場規模:製造サービス別
11 世界のエクソソーム研究市場規模:地域別
12 競争状況
13 企業情報
14 付録

❖ レポートの目次 ❖

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 MARKETS COVERED 33
1.3.1 MARKET SCOPE 33
1.3.2 YEARS CONSIDERED 34
1.3.3 CURRENCY CONSIDERED 34
1.4 STAKEHOLDERS 34
1.5 SUMMARY OF CHANGES 35
1.5.1 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 37
FIGURE 2 BREAKDOWN OF PRIMARIES: EXOSOME RESEARCH MARKET 38
2.2 MARKET ESTIMATION METHODOLOGY 38
FIGURE 3 EXOSOME RESEARCH MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 38
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 39
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 40
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 40
2.3 MARKET GROWTH RATE PROJECTIONS 41
FIGURE 6 EXOSOME RESEARCH MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 42
FIGURE 7 EXOSOME RESEARCH MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 42
2.3.1 DATA TRIANGULATION 43
FIGURE 8 DATA TRIANGULATION METHODOLOGY 43
2.4 LIMITATIONS 44
2.5 RESEARCH ASSUMPTIONS 44
2.6 RISK ANALYSIS 44
2.7 RECESSION IMPACT 45
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH) 45
TABLE 2 US: HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 46
TABLE 3 US: HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 46
3 EXECUTIVE SUMMARY 47
FIGURE 9 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 10 EXOSOME RESEARCH MARKET, BY INDICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 11 EXOSOME RESEARCH MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 EXOSOME RESEARCH MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 49
FIGURE 13 EXOSOME RESEARCH MARKET: GEOGRAPHICAL SNAPSHOT 50
4 PREMIUM INSIGHTS 51
4.1 EXOSOME RESEARCH MARKET OVERVIEW 51
FIGURE 14 RISING INVESTMENTS IN PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH 51
4.2 EXOSOME RESEARCH MARKET: BY MANUFACTURING SERVICE 52
FIGURE 15 STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES TO HOLD LARGEST MARKET SHARE TILL 2028 52
4.3 ASIA PACIFIC: EXOSOME RESEARCH MARKET SHARE, BY APPLICATION & COUNTRY (2022) 53
FIGURE 16 BIOMARKERS ACCOUNTED FOR LARGEST SHARE OF APPLICATION SEGMENT IN 2022 53
4.4 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2023 VS. 2028 (USD MILLION) 54
FIGURE 17 LUNG CANCER SEGMENT CONTINUES TO DOMINATE MARKET IN 2028 54
4.5 EXOSOME RESEARCH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 18 NORTH AMERICA AND EUROPE MARKETS TO SHOW HIGHER GROWTH 54
4.6 EXOSOME RESEARCH MARKET SHARE, BY END USER, 2022 55
FIGURE 19 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 20 EXOSOME RESEARCH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
TABLE 4 EXOSOME RESEARCH MARKET: IMPACT ANALYSIS 57
5.2.1 DRIVERS 57
5.2.1.1 Increasing investment in pharmaceutical and life sciences research 57
5.2.1.2 Rising cancer prevalence 58
TABLE 5 GLOBAL CANCER INCIDENCE, 2022 VS. 2025 58
5.2.1.3 Increasing interest in exosome-based procedures 59
5.2.2 RESTRAINTS 59
5.2.2.1 Technical complexity of exosome isolation and technological limitations 59
5.2.2.2 Regulatory uncertainty in exosome research 60
5.2.3 OPPORTUNITIES 60
5.2.3.1 Rising investments in emerging countries for exosome research 60
5.2.3.2 Growing interest in exosome-based therapeutics 61
5.2.3.3 Increasing demand for personalized medicine 61
5.2.4 CHALLENGES 62
5.2.4.1 Lack of gold standard protocols for exosome development and production 62
5.2.4.2 Limited understanding of cargo loading 62
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 63
FIGURE 21 REVENUE SHIFT AND NEW POCKETS FOR EXOSOME PROVIDERS 63
5.4 PRICING ANALYSIS 63
TABLE 6 AVERAGE SELLING PRICES OF KEY PLAYERS, BY PRODUCT 64
TABLE 7 REGIONAL VARIATIONS IN PRODUCT COSTS 64
5.5 VALUE CHAIN ANALYSIS 64
FIGURE 22 VALUE CHAIN ANALYSIS OF EXOSOME RESEARCH: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 64
5.6 SUPPLY CHAIN ANALYSIS 65
FIGURE 23 EXOSOME RESEARCH MARKET: SUPPLY CHAIN ANALYSIS 66
5.7 ECOSYSTEM/MARKET MAP 66
FIGURE 24 EXOSOME RESEARCH MARKET ECOSYSTEM 66
TABLE 8 EXOSOME RESEARCH MARKET: ROLE IN ECOSYSTEM 67
5.8 TECHNOLOGY ANALYSIS 68
TABLE 9 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME ISOLATION 68
TABLE 10 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME CHARACTERIZATION 69
TABLE 11 EXOSOME RESEARCH MARKET: TECHNOLOGY ANALYSIS—EXOSOME ANALYSIS 69
5.9 PATENT ANALYSIS 70
FIGURE 25 PATENT APPLICATIONS FOR EXOSOME RESEARCH MARKET, JANUARY 2013–OCTOBER 2023 70
TABLE 12 INDICATIVE LIST OF PATENTS IN EXOSOME RESEARCH MARKET 71
5.10 KEY CONFERENCES AND EVENTS, 2024–2025 72
TABLE 13 EXOSOME RESEARCH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 72
5.11 REGULATORY ANALYSIS 73
5.11.1 NORTH AMERICA 74
5.11.1.1 US 74
5.11.1.2 Canada 74
5.11.2 EUROPE 74
5.11.2.1 Germany 74
5.11.2.2 France 75
5.11.2.3 UK 75
5.11.3 ASIA PACIFIC 75
5.11.3.1 China 75
5.11.3.2 Japan 76
5.11.3.3 India 76
5.11.4 REST OF THE WORLD 76
5.11.4.1 Brazil 76
5.11.4.2 Argentina 76
5.11.4.3 Saudi Arabia 77
5.11.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
TABLE 17 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
5.12 PORTER’S FIVE FORCES ANALYSIS 79
TABLE 18 EXOSOME RESEARCH MARKET: PORTER’S FIVE FORCES ANALYSIS 79
5.12.1 THREAT OF NEW ENTRANTS 80
5.12.2 THREAT OF SUBSTITUTES 80
5.12.3 BARGAINING POWER OF SUPPLIERS 80
5.12.4 BARGAINING POWER OF BUYERS 80
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 81
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 81
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 81
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF EXOSOME PRODUCTS & SERVICES 81
5.13.2 BUYING CRITERIA FOR EXOSOME PRODUCTS & SERVICES 82
FIGURE 27 KEY BUYING CRITERIA FOR END USERS 82
6 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE 84
6.1 INTRODUCTION 85
TABLE 19 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 85
6.2 KITS & REAGENTS 85
TABLE 20 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 86
TABLE 21 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 22 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 23 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 24 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 87
6.2.1 ANTIBODIES 87
6.2.1.1 High demand for exosome-based markers for disease detection to propel growth 87
TABLE 25 EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 26 NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 27 EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 28 ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.2.2 ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS 89
6.2.2.1 Availability of rapid and easy-to-use kits & reagents to ensure sustained demand 89
TABLE 29 EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 90
TABLE 30 NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 31 EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 32 ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
6.2.3 OTHER KITS & REAGENTS 91
TABLE 33 OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 34 NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 35 EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 36 ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
6.3 INSTRUMENTS 93
6.3.1 DEMAND FOR SCALABLE EXOSOME DEVELOPMENT VIA HIGH-THROUGHPUT SYSTEMS TO DRIVE GROWTH 93
TABLE 37 EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 38 NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 39 EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 40 ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 94
6.4 SERVICES 95
6.4.1 LACK OF IN-HOUSE RESOURCES TO SUPPORT GROWTH OF SERVICES SECTOR 95
TABLE 41 EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 42 NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 43 EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 44 ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 96
7 EXOSOME RESEARCH MARKET, BY INDICATION 97
7.1 INTRODUCTION 98
TABLE 45 EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 98
7.2 CANCER 98
TABLE 46 EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 47 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 48 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 49 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 50 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 100
7.2.1 LUNG CANCER 100
7.2.1.1 Increasing prevalence and advancements in instruments and assays for liquid biopsy to drive market 100
TABLE 51 EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 52 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 53 EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 54 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 102
7.2.2 BREAST CANCER 102
7.2.2.1 High prevalence and increasing awareness to drive market 102
TABLE 55 EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 56 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 57 EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 58 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 104
7.2.3 PROSTATE CANCER 104
7.2.3.1 Effectiveness of liquid biopsy in detecting prostate cancer before surgery to support market growth 104
TABLE 59 EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 60 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 61 EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 62 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 106
7.2.4 COLORECTAL CANCER 106
7.2.4.1 Increasing exosome-based research and projects to propel market 106
TABLE 63 EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 64 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 65 EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 66 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2021–2028 (USD MILLION) 108
7.2.5 OTHER CANCERS 108
TABLE 67 EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 68 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 69 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 70 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
7.3 NEURODEGENERATIVE DISEASES 110
7.3.1 POTENTIAL APPLICATIONS OF SALIVARY EXOSOMAL CARGO CONTENT IN TREATMENT TO DRIVE MARKET 110
TABLE 71 EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2021–2028 (USD MILLION) 110
TABLE 72 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 73 EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 74 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 111
7.4 CARDIOVASCULAR DISEASES 112
7.4.1 EXPANDING RESEARCH ON CVD APPLICATIONS TO PROPEL SEGMENT GROWTH 112
TABLE 75 EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION) 112
TABLE 76 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 77 EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 78 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 113
7.5 INFECTIOUS DISEASES 113
7.5.1 POTENTIAL FOR DEEPER UNDERSTANDING OF INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET 113
TABLE 79 EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2021–2028 (USD MILLION) 114
TABLE 80 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 81 EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 82 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION) 115
7.6 OTHER INDICATIONS 115
TABLE 83 EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION) 116
TABLE 84 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 85 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 86 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
8 EXOSOME RESEARCH MARKET, BY APPLICATION 118
8.1 INTRODUCTION 119
TABLE 87 EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
8.2 BIOMARKERS 119
8.2.1 BIOMARKERS TO HOLD LARGEST SHARE OF APPLICATIONS MARKET 119
TABLE 88 EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2021–2028 (USD MILLION) 120
TABLE 89 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 90 EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 91 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2021–2028 (USD MILLION) 121
8.3 VACCINE DEVELOPMENT 121
8.3.1 GROWING INTEREST IN EXOSOMES IN INFECTIOUS DISEASE THERAPEUTICS TO DRIVE MARKET 121
TABLE 92 EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 93 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 94 EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 95 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2021–2028 (USD MILLION) 122
8.4 TISSUE REGENERATION 123
8.4.1 MINIMAL SIDE EFFECTS AND HIGH EFFICACY OF EXOSOMES TO SUPPORT ADOPTION 123
TABLE 96 EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 97 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 98 EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 99 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 124
8.5 OTHER APPLICATIONS 124
TABLE 100 EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 101 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 102 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 103 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 126
9 EXOSOME RESEARCH MARKET, BY END USER 127
9.1 INTRODUCTION 128
TABLE 104 EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 128
9.2 ACADEMIC & RESEARCH INSTITUTES 128
9.2.1 ACADEMIC & RESEARCH INSTITUTES TO HOLD LARGEST SHARE OF END-USER MARKET 128
TABLE 105 EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 129
TABLE 106 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 107 EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 129
TABLE 108 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 130
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 130
9.3.1 SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET 130
TABLE 109 EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 130
TABLE 110 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 111 EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131
TABLE 112 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 131
9.4 HOSPITALS & CLINICAL TESTING LABORATORIES 132
9.4.1 RISING ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET 132
TABLE 113 EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2021–2028 (USD MILLION) 132
TABLE 114 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 115 EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 116 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION) 133
10 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE 134
10.1 INTRODUCTION 135
TABLE 117 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE, 2021–2028 (USD MILLION) 135
10.2 STEM CELL-DERIVED EXOSOME MANUFACTURING 135
10.2.1 RISING DEMAND FOR MSC EXOSOMES IN THERAPEUTICS TO DRIVE MARKET 135
10.3 DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING 136
10.3.1 SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO PROPEL GROWTH 136
10.4 OTHER EXOSOME MANUFACTURING SERVICES 136
11 EXOSOME RESEARCH MARKET, BY REGION 137
11.1 INTRODUCTION 138
TABLE 118 EXOSOME RESEARCH MARKET, KEYWORD ANALYSIS (2001-2022) 138
TABLE 119 EXOSOME RESEARCH MARKET, BY REGION, 2021–2028 (USD MILLION) 138
11.2 NORTH AMERICA 139
FIGURE 28 NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT 139
TABLE 120 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
TABLE 121 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 140
TABLE 122 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 123 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 141
TABLE 124 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 125 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 126 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 142
11.2.1 US 142
11.2.1.1 HIGH BURDEN OF CANCER AND FAVORABLE PUBLIC & PRIVATE FUNDING FOR RESEARCH TO DRIVE MARKET 142
TABLE 127 US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 143
TABLE 128 US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 129 US: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 144
TABLE 130 US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 131 US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 132 US: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 145
11.2.2 CANADA 145
11.2.2.1 INCREASING FUNDING FOR GENOME-BASED MEDICAL TREATMENTS TO SUPPORT MARKET GROWTH 145
TABLE 133 CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 146
TABLE 134 CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 135 CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 146
TABLE 136 CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 137 CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 138 CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 148
11.2.3 NORTH AMERICA: RECESSION IMPACT 148
11.3 EUROPE 148
FIGURE 29 EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT 149
TABLE 139 EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150
TABLE 140 EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 150
TABLE 141 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 142 EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 151
TABLE 143 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 144 EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 152
TABLE 145 EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 152
11.3.1 GERMANY 152
11.3.1.1 Germany to dominate European market 152
TABLE 146 GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 153
TABLE 147 GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 148 GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 154
TABLE 149 GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 150 GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 151 GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 155
11.3.2 UK 155
11.3.2.1 Growing life sciences industry to drive market 155
TABLE 152 UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 156
TABLE 153 UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 154 UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 157
TABLE 155 UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 156 UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 157 UK: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 158
11.3.3 FRANCE 158
11.3.3.1 Strong collaborative network between biotechnology entities and research institutes to support growth 158
TABLE 158 FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 159
TABLE 159 FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 159
TABLE 160 FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 159
TABLE 161 FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 160
TABLE 162 FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 160
TABLE 163 FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 161
11.3.4 REST OF EUROPE 161
TABLE 164 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 162
TABLE 165 REST OF EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 166 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 163
TABLE 167 REST OF EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 163
TABLE 168 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 164
TABLE 169 REST OF EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 164
11.3.5 EUROPE: RECESSION IMPACT 165
11.4 ASIA PACIFIC 165
TABLE 170 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 165
TABLE 171 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 166
TABLE 172 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 173 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 167
TABLE 174 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 167
TABLE 175 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 168
TABLE 176 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 168
11.4.1 CHINA 168
11.4.1.1 China to hold largest share in APAC market 168
TABLE 177 CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 178 CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 179 CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 170
TABLE 180 CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 170
TABLE 181 CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 171
TABLE 182 CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 171
11.4.2 JAPAN 171
11.4.2.1 High cancer prevalence and increasing healthcare expenditure to drive market 171
TABLE 183 TOTAL NUMBER OF CLINICAL TRIALS IN JAPAN, BY THERAPEUTIC AREA, 2020 VS. 2022 172
TABLE 184 JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 185 JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 186 JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 173
TABLE 187 JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 188 JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 189 JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 174
11.4.3 REST OF ASIA PACIFIC 174
TABLE 190 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 191 REST OF ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 192 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 176
TABLE 193 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 194 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 177
TABLE 195 REST OF ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 177
11.4.4 ASIA PACIFIC: RECESSION IMPACT 177
11.5 REST OF THE WORLD 178
TABLE 196 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 178
TABLE 197 REST OF THE WORLD: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 179
TABLE 198 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY INDICATION, 2021–2028 (USD MILLION) 179
TABLE 199 REST OF THE WORLD: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021–2028 (USD MILLION) 180
TABLE 200 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 180
TABLE 201 REST OF THE WORLD: EXOSOME RESEARCH MARKET, BY END USER, 2021–2028 (USD MILLION) 181
11.5.1 REST OF THE WORLD: RECESSION IMPACT 181
12 COMPETITIVE LANDSCAPE 182
12.1 OVERVIEW 182
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 182
FIGURE 30 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020- 2023 183
12.3 REVENUE ANALYSIS 184
FIGURE 31 REVENUE ANALYSIS OF TOP FIVE MARKET PLAYERS (2018–2022) 184
12.4 MARKET SHARE ANALYSIS 184
TABLE 202 EXOSOME RESEARCH MARKET: DEGREE OF COMPETITION 185
12.5 COMPANY EVALUATION MATRIX 186
12.5.1 STARS 186
12.5.2 EMERGING LEADERS 187
12.5.3 PERVASIVE 187
12.5.4 EMERGING COMPANIES 187
FIGURE 33 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2022 187
12.5.5 COMPANY FOOTPRINT 188
TABLE 203 COMPANY FOOTPRINT (25 COMPANIES) 188
TABLE 204 PRODUCT & SERVICE FOOTPRINT (25 COMPANIES) 189
TABLE 205 GEOGRAPHIC FOOTPRINT (25 COMPANIES) 190
12.6 START-UP/SME EVALUATION MATRIX 191
12.6.1 PROGRESSIVE COMPANIES 191
12.6.2 STARTING BLOCKS 191
12.6.3 RESPONSIVE COMPANIES 191
12.6.4 DYNAMIC COMPANIES 191
FIGURE 34 EXOSOME RESEARCH MARKET: START-UP/SME EVALUATION MATRIX, 2022 192
12.6.5 COMPETITIVE BENCHMARKING 193
TABLE 206 EXOSOME RESEARCH MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 193
TABLE 207 EXOSOME RESEARCH MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS [START-UPS/SMES] 194
12.7 COMPETITIVE SCENARIO 195
13 COMPANY PROFILES 196
13.1 KEY PLAYERS 196
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1.1 THERMO FISHER SCIENTIFIC INC. 196
TABLE 208 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 196
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022) 197
13.1.2 QIAGEN 200
TABLE 209 QIAGEN: COMPANY OVERVIEW 200
FIGURE 36 QIAGEN: COMPANY SNAPSHOT (2022) 201
13.1.3 LONZA 203
TABLE 210 LONZA: COMPANY OVERVIEW 203
FIGURE 37 LONZA: COMPANY SNAPSHOT (2022) 204
13.1.4 SYSTEM BIOSCIENCES, LLC 206
TABLE 211 SYSTEM BIOSCIENCES, LLC: COMPANY OVERVIEW 206
13.1.5 BIO-TECHNE 208
TABLE 212 BIO-TECHNE: COMPANY OVERVIEW 208
FIGURE 38 BIO-TECHNE: COMPANY SNAPSHOT (2022) 209
13.1.6 DANAHER CORPORATION 212
TABLE 213 DANAHER CORPORATION: COMPANY OVERVIEW 212
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2022) 213
13.1.7 AMSBIO 215
TABLE 214 AMSBIO: COMPANY OVERVIEW 215
13.1.8 ROOSTERBIO, INC. 217
TABLE 215 ROOSTERBIO, INC.: COMPANY OVERVIEW 217
13.1.9 MILTENYI BIOTEC 219
TABLE 216 MILTENYI BIOTEC: COMPANY OVERVIEW 219
13.1.10 NORGEN BIOTEK CORP. 220
TABLE 217 NORGEN BIOTEK CORP.: COMPANY OVERVIEW 220
13.2 OTHER PLAYERS 222
13.2.1 AETHLON MEDICAL, INC. 222
13.2.2 ANJARIUM BIOSCIENCES AG 222
13.2.3 CILOA 223
13.2.4 INNOVAPREP, LLC 223
13.2.5 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC, 224
13.2.6 ILIAS BIOLOGICS INC. 224
13.2.7 UNCHAINED LABS 225
13.2.8 RION INC. 225
13.2.9 CELL GUIDANCE SYSTEMS LLC 226
13.2.10 INOVIQ 226
13.2.11 NX PHARMAGEN 227
13.2.12 EXOPHARM 227
13.2.13 EVERZOM 228
13.2.14 NANOSOMIX 229
13.2.15 CREATIVE BIOLABS 229
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 231
14.1 DISCUSSION GUIDE 231
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 235
14.3 CUSTOMIZATION OPTIONS 237
14.4 RELATED REPORTS 237
14.5 AUTHOR DETAILS 238



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ エクソソーム研究の世界市場予測(~2028):製品・サービス別、疾患別、用途別、製造サービス別(Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆